Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07882420

Role of Artificial Intelligence in Breast Cancer Screening Via Mammography

Conditions: Breast Cancer

Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 1222
Sponsor: Centre Antoine Lacassagne

Location: Institut Paoli Calmette Marseille

Summary

to evaluate the diagnostic performance of radiologists using the Transpara™ Incepto® software to interpret 2D mammograms with tomosynthesis as part of breast cancer screening

Eligibility Criteria

Inclusion Criteria: * A woman referred for a bilateral mammogram as part of individual or organised screening, * Patient aged 18 or over, * A patient who has read the information leaflet and signed the informed consent form, * A patient with health insurance cover. Exclusion Criteria: * Patients with a history of breast cancer, * Patients with a history of breast surgery (cosmetic and/or therapeutic), * Patients with a history of radiotherapy to the breast, * Vulnerable populations and participants as defined in Articles 64 to 68 of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07882420). StuddyBuddy aggregates publicly available trial information.